{"id":"https://openalex.org/W7221575558","doi":"https://doi.org/10.3389/fonc.2026.1952158","title":"Spatial architecture shapes programmed cell death-associated immune niches and therapeutic resistance in clear cell renal cell carcinoma","display_name":"Spatial architecture shapes programmed cell death-associated immune niches and therapeutic resistance in clear cell renal cell carcinoma","publication_year":2026,"publication_date":"2026-10-12","ids":{"openalex":"https://openalex.org/W7221575558","doi":"https://doi.org/10.3389/fonc.2026.1952158","pmid":"https://pubmed.ncbi.nlm.nih.gov/42936299","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13697304"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1952158","doi":"https://doi.org/10.3389/fonc.2026.1952158","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1952158","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1952158/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1952158/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5158448625","display_name":"Yu Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu Yin","raw_affiliation_strings":["Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","institution_ids":["https://openalex.org/I114539943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008130745","display_name":"Junlong Wang","orcid":"https://orcid.org/0000-0002-3969-3321","observed_orcids":["https://orcid.org/0000-0002-3969-3321"]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junlong Wang","raw_affiliation_strings":["Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","institution_ids":["https://openalex.org/I114539943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107048255","display_name":"Dengxiong Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Dengxiong Li","raw_affiliation_strings":["Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","institution_ids":["https://openalex.org/I114539943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040233161","display_name":"Dandan Qiu","orcid":"https://orcid.org/0000-0001-7910-8409","observed_orcids":["https://orcid.org/0000-0001-7910-8409"]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Dandan Qiu","raw_affiliation_strings":["Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)","institution_ids":["https://openalex.org/I114539943"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040233161","https://openalex.org/A5107048255"],"corresponding_institution_ids":["https://openalex.org/I114539943"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5482519,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1952158","last_page":"1952158"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4530999958515167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4530999958515167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.2386000007390976,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.195700004696846,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":1.0},{"id":"https://openalex.org/keywords/programmed-cell-death","display_name":"programmed cell death","score":0.925000011920929},{"id":"https://openalex.org/keywords/immune-niches","display_name":"immune niches","score":0.7379999756813049},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7080000042915344},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.5649999976158142},{"id":"https://openalex.org/keywords/regulated-cell-death","display_name":"regulated cell death","score":0.7689999938011169},{"id":"https://openalex.org/keywords/ferroptosis","display_name":"ferroptosis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pyroptosis","display_name":"pyroptosis","score":1.0},{"id":"https://openalex.org/keywords/necroptosis","display_name":"necroptosis","score":1.0},{"id":"https://openalex.org/keywords/panoptosis","display_name":"PANoptosis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/efferocytosis","display_name":"efferocytosis","score":0.8759999871253967},{"id":"https://openalex.org/keywords/tam-receptors","display_name":"TAM receptors","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7450000047683716},{"id":"https://openalex.org/keywords/spatial-biomarkers","display_name":"spatial biomarkers","score":0.6790000200271606},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5740000009536743},{"id":"https://openalex.org/keywords/hif-2alpha-inhibitor","display_name":"HIF-2\u03b1 inhibitor","score":0.8169999718666077},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C2781278892","wikidata":"https://www.wikidata.org/wiki/Q18556340","display_name":"Clear cell renal cell carcinoma","level":3,"score":0.8648999929428101},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6700000166893005},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.6305999755859375},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6133000254631042},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.5882999897003174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.529699981212616},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4941999912261963},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.45570001006126404},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4453999996185303},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4352000057697296},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3603000044822693},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3301999866962433},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.3294999897480011},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3125},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3100999891757965},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.2973000109195709},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.2903999984264374},{"id":"https://openalex.org/C2777895019","wikidata":"https://www.wikidata.org/wiki/Q1425962","display_name":"Foam cell","level":4,"score":0.28360000252723694},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.2806999981403351},{"id":"https://openalex.org/C20299238","wikidata":"https://www.wikidata.org/wiki/Q363928","display_name":"Lipocalin","level":2,"score":0.26820001006126404},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.25920000672340393},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.2540999948978424}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1952158","doi":"https://doi.org/10.3389/fonc.2026.1952158","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1952158","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1952158/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13697304","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13697304/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13697304/pdf/fonc-16-1952158.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:42936299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42936299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c0d3e312f6074ba48a939728e3fc5518","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c0d3e312f6074ba48a939728e3fc5518","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1952158","doi":"https://doi.org/10.3389/fonc.2026.1952158","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1952158","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1952158/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221575558.pdf","grobid_xml":"https://content.openalex.org/works/W7221575558.grobid-xml"},"referenced_works_count":101,"referenced_works":["https://openalex.org/W1864325817","https://openalex.org/W1882905539","https://openalex.org/W1997183854","https://openalex.org/W2002490399","https://openalex.org/W2010991736","https://openalex.org/W2023122823","https://openalex.org/W2037342985","https://openalex.org/W2067632426","https://openalex.org/W2080202443","https://openalex.org/W2111867681","https://openalex.org/W2120626244","https://openalex.org/W2132161879","https://openalex.org/W2146810078","https://openalex.org/W2157817512","https://openalex.org/W2320177900","https://openalex.org/W2335012284","https://openalex.org/W2461271870","https://openalex.org/W2462773201","https://openalex.org/W2536322725","https://openalex.org/W2549188196","https://openalex.org/W2550324626","https://openalex.org/W2607935491","https://openalex.org/W2608687752","https://openalex.org/W2611919322","https://openalex.org/W2612805962","https://openalex.org/W2768892314","https://openalex.org/W2782183686","https://openalex.org/W2785803176","https://openalex.org/W2788640168","https://openalex.org/W2792937256","https://openalex.org/W2805302875","https://openalex.org/W2806219344","https://openalex.org/W2890156794","https://openalex.org/W2913745075","https://openalex.org/W2914311347","https://openalex.org/W2932111434","https://openalex.org/W2943793201","https://openalex.org/W2947880033","https://openalex.org/W2966214074","https://openalex.org/W2980472864","https://openalex.org/W2981179816","https://openalex.org/W2983652778","https://openalex.org/W2997855099","https://openalex.org/W3011500848","https://openalex.org/W3012485477","https://openalex.org/W3029490475","https://openalex.org/W3047618013","https://openalex.org/W3087176574","https://openalex.org/W3096713247","https://openalex.org/W3108493784","https://openalex.org/W3123185162","https://openalex.org/W3123922203","https://openalex.org/W3131063362","https://openalex.org/W3133932842","https://openalex.org/W3134949580","https://openalex.org/W3134959125","https://openalex.org/W3135213711","https://openalex.org/W3168048358","https://openalex.org/W3197986920","https://openalex.org/W3215189579","https://openalex.org/W4200236047","https://openalex.org/W4213455992","https://openalex.org/W4214620261","https://openalex.org/W4284889683","https://openalex.org/W4285795954","https://openalex.org/W4294266034","https://openalex.org/W4298131985","https://openalex.org/W4304118718","https://openalex.org/W4309825858","https://openalex.org/W4313650150","https://openalex.org/W4322422773","https://openalex.org/W4376107652","https://openalex.org/W4378083091","https://openalex.org/W4380627560","https://openalex.org/W4386624514","https://openalex.org/W4386764598","https://openalex.org/W4390233733","https://openalex.org/W4391380523","https://openalex.org/W4393318695","https://openalex.org/W4394981274","https://openalex.org/W4400113535","https://openalex.org/W4401305294","https://openalex.org/W4401779682","https://openalex.org/W4405917544","https://openalex.org/W4407870144","https://openalex.org/W4409276434","https://openalex.org/W4410940500","https://openalex.org/W4411195500","https://openalex.org/W4412015410","https://openalex.org/W4412015443","https://openalex.org/W4412078204","https://openalex.org/W4412819491","https://openalex.org/W4414040768","https://openalex.org/W4414797199","https://openalex.org/W4416813010","https://openalex.org/W7119489338","https://openalex.org/W7119540139","https://openalex.org/W7126434774","https://openalex.org/W7161152456","https://openalex.org/W7161634597","https://openalex.org/W7162632907"],"related_works":["https://openalex.org/W7169861951","https://openalex.org/W4392460831","https://openalex.org/W7168377036","https://openalex.org/W7155080338","https://openalex.org/W2935989276","https://openalex.org/W4306160634","https://openalex.org/W4367693291","https://openalex.org/W2069512383","https://openalex.org/W4389600042","https://openalex.org/W3135213711"],"abstract_inverted_index":{"Clear":[0],"cell":[1,3,42,95,107],"renal":[2],"carcinoma":[4],"(ccRCC)":[5],"is":[6,98,226],"characterized":[7],"by":[8],"VHL-HIF":[9],"pathway":[10],"alterations,":[11],"lipid":[12],"remodeling,":[13],"abnormal":[14],"angiogenesis,":[15],"and":[16,37,60,67,70,82,133,155,190,196,214,216,235,246],"marked":[17],"immune":[18,48,158,170,244],"heterogeneity.":[19,90],"These":[20],"features":[21],"create":[22],"a":[23,162,168,173],"highly":[24],"vascular":[25,32,52],"yet":[26],"unevenly":[27],"perfused":[28],"microenvironment":[29],"in":[30,110,119,177],"which":[31,178,223],"dysfunction,":[33],"hypoxia,":[34],"stromal":[35],"barriers,":[36],"myeloid":[38],"clearance":[39],"influence":[40],"whether":[41],"death":[43,96,108,149,186],"becomes":[44],"immunologically":[45],"productive.":[46],"Although":[47],"checkpoint":[49],"inhibitor":[50],"combinations,":[51],"endothelial":[53],"growth":[54],"factor":[55],"receptor":[56],"tyrosine":[57],"kinase":[58],"inhibitors,":[59],"HIF-2\u03b1":[61],"inhibitors":[62],"have":[63],"improved":[64],"outcomes,":[65],"primary":[66],"acquired":[68],"resistance":[69],"discordant":[71],"responses":[72],"among":[73],"lesions":[74],"remain":[75],"common.":[76],"Bulk":[77],"PD-L1":[78],"expression,":[79],"immune-cell":[80],"abundance,":[81],"cell-death-related":[83],"transcript":[84],"signatures":[85],"do":[86],"not":[87],"resolve":[88],"this":[89],"Following":[91],"current":[92],"nomenclature,":[93],"regulated":[94],"(RCD)":[97],"the":[99,111,120,140,143,148,156],"mechanistically":[100],"preferred":[101],"umbrella":[102],"term;":[103],"we":[104],"retain":[105],"programmed":[106],"(PCD)":[109],"conceptual":[112],"label":[113],"because":[114],"it":[115],"remains":[116],"widely":[117],"used":[118],"RCC":[121],"oncology":[122],"literature,":[123],"while":[124],"requiring":[125],"RCD":[126,220],"execution-level":[127],"evidence":[128,225],"for":[129,222],"mechanistic":[130],"claims.":[131],"Single-cell":[132],"spatial":[134,174,233],"multi-omics":[135],"studies":[136],"increasingly":[137],"show":[138],"that":[139,238],"identity":[141],"of":[142,147,152],"dying":[144],"cell,":[145],"execution":[146,242],"program,":[150],"accessibility":[151],"death-derived":[153],"material,":[154],"recipient":[157],"cells":[159],"operate":[160],"as":[161,172],"coupled":[163],"local":[164],"system.":[165],"We":[166,229],"define":[167],"PCD-associated":[169],"niche":[171],"tissue":[175,197],"state":[176],"representative,":[179],"non-exclusive":[180],"immune-routing":[181],"axes":[182],"can":[183],"direct":[184],"tumor-cell":[185],"toward":[187],"cDC1-mediated":[188],"cross-presentation":[189],"adaptive":[191],"antitumor":[192],"immunity,":[193],"TAM-dominant":[194],"efferocytosis":[195],"repair,":[198],"or":[199],"intermediate":[200],"mixed":[201],"states.":[202],"This":[203],"Review":[204],"focuses":[205],"predominantly":[206],"on":[207],"ccRCC,":[208],"evaluates":[209],"ferroptosis,":[210],"apoptosis,":[211],"pyroptosis,":[212],"necroptosis,":[213],"PANoptosis,":[215],"briefly":[217],"considers":[218],"emerging":[219],"modalities":[221],"ccRCC":[224],"less":[227],"mature.":[228],"further":[230],"propose":[231],"composite":[232],"biomarkers":[234],"mechanism-guided":[236],"combinations":[237],"link":[239],"cellular":[240],"source,":[241],"evidence,":[243],"routing,":[245],"clinical":[247],"outcome.":[248]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2026-10-13T00:00:00"}